Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

59.03
Delayed Data
As of Oct 20
 +0.07 / +0.12%
Today’s Change
37.35
Today|||52-Week Range
63.77
+52.53%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close58.96
Today’s open58.59
Day’s range57.71 - 60.56
Volume1,279,507
Average volume (3 months)853,984
Market cap$5.2B
Dividend yield--
Data as of 4:00pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-48.04%
Earnings growth (next 5 years)-13.59%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book16.29

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp+1.62+3.41%
TECHBio-Techne Corp+0.79+0.64%
JUNOJuno Therapeutics In...+0.31+0.71%
BLUEbluebird bio Inc+3.10+2.22%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Director, Chief Executive &
Financial Officer
Kevin Charles Gorman
Chief Research Officer
Dimitri E. Grigoriadis
Corporate headquarters
San Diego, California

Forecasts